https://www.selleckchem.com/pr....oducts/pha-767491.ht
Glaucoma is the leading cause of global irreversible blindness, oftenassociated with raised intraocular pressure (IOP). Where medical or laser treatment has failed or is not tolerated, surgery is often required. Minimally-invasive surgical approaches have been developed in recent years to reduce IOPwith lower surgical risks. Supraciliary microstent surgery for the treatment of open-angle glaucoma (OAG) is one such approach. To evaluatethe efficacy and safety of supraciliary microstent surgery for the treatment of OAG, and to compare
Curtir
Comentario
Compartilhar
